Frequency therapy, also known as directed soundwave therapy, exposes particular frequencies that slow or stop the growth of cancerous cells without harming the healthy tissues.
Frequency-selective cancer therapy, which uses TheraBionic P1, involves applying low RF fields to prevent tumoral growth but not to affect healthy cells.
It was also found that the targeted frequency therapies have fewer side effects, thus improving patients' tolerance and quality of life.
Thus, devices such as the TheraBionic P1 can be used at home to complement conventional therapy and increase patients' comfort.
For instance, targeted frequency therapies are not invasive, making them attractive options compared to harsh treatments.
Some ongoing experiments reveal that low-frequency specific applied therapies may prove helpful in reducing tumor size and increasing survival chances.
Targeted frequency therapy can prevent tumor growth by utilizing particular electromagnetic frequencies while maintaining healthy cells and enhancing treatment effectiveness.